Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections
<p>Parasitic filarial nematodes cause debilitating infections in people in resource-limited countries. A clinically validated approach to eliminating worms uses a 4- to 6-week course of doxycycline that targets <em>Wolbachia</em>, a bacterial endosymbiont required for worm viabilit...
Main Authors: | Bakowski, MA, Shiroodi, RK, Liu, R, Olejniczak, J, Yang, B, Gagaring, K, Guo, H, White, PM, Chappell, L, Debec, A, Landmann, F, Dubben, B, Lenz, F, Struever, D, Ehrens, A, Frohberger, SJ, Sjoberg, H, Pionnier, N, Murphy, E, Archer, J, Steven, A, Chunda, VC, Fombad, FF, Chounna, PW, Njouendou, AJ, Metuge, HM, Ndzeshang, BL, Gandjui, NV, Akumtoh, DN, Kwenti, TDB, Woods, AK, Joseph, SB, Hull, MV, Xiong, W, Kuhen, KL, Taylor, MJ, Wanji, S, Turner, JD, Hübner, MP, Hoerauf, A, Chatterjee, AK, Roland, J, Tremblay, MS, Schultz, PG, Sullivan, W, Chu, X-J, Petrassi, HM, McNamara, CW |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Association for the Advancement of Science
2019
|
Similar Items
-
Mouse models of Loa loa
by: Pionnier, NP, et al.
Published: (2019) -
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models
by: Sjoberg, HT, et al.
Published: (2019) -
Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections
by: Malina A. Bakowski, et al.
Published: (2019-07-01) -
Molecular Docking Simulation Studies Identifies Potential Natural Product Derived-Antiwolbachial Compounds as Filaricides against Onchocerciasis
by: Samuel K. Kwofie, et al.
Published: (2021-11-01) -
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis
by: Taylor, MJ, et al.
Published: (2019)